Pierre Mugabo

Publication Activity (10 Years)

Years Active: 2019-2021
Publications (10 Years): 6

Top Topics

Methicillin Resistant Staphylococcus Aureus

Molecularly Imprinted

Human Immunodeficiency Virus

Top Venues

British journal of clinical pharmacology

European journal of drug metabolism and pharmacokinetics

This page only lists publications with an associated author ORCID identifier.

Publications

Onyinye Onyeka Akunne, Pierre Mugabo, Andrew C Argent
Pharmacokinetics of Vancomycin in Critically Ill Children: A Systematic Review. European journal of drug metabolism and pharmacokinetics (2021)
Pierre Mugabo, Mwila Mulubwa
Ethionamide population pharmacokinetics/pharmacodynamics and therapeutic implications in South African adult patients with drug-resistant tuberculosis. British journal of clinical pharmacology 87 (10) (2021)
Mwila Mulubwa, Heletje Aletta Griesel, Pierre Mugabo, Ricky Dippenaar, Lizelle van Wyk
Assessment of Vancomycin Pharmacokinetics and Dose Regimen Optimisation in Preterm Neonates. Drugs in R&D 20 (2) (2020)
Mwila Mulubwa, Pierre Mugabo
Amount of Cycloserine Emanating from Terizidone Metabolism and Relationship with Hepatic Function in Patients with Drug-Resistant Tuberculosis. Drugs in R&D 19 (3) (2020)
Pierre Mugabo, Mwila Mulubwa
Population Pharmacokinetic Modelling of Pyrazinamide and Pyrazinoic Acid in Patients with Multi-Drug Resistant Tuberculosis. European journal of drug metabolism and pharmacokinetics 44 (4) (2019)
Mwila Mulubwa, Pierre Mugabo
Steady-state population pharmacokinetics of terizidone and its metabolite cycloserine in patients with drug-resistant tuberculosis. British journal of clinical pharmacology 85 (9) (2019)